Skip to Main Content
Table 2

PFS by p53 status, hormone receptor status, nuclear grade, and pCR

No. of patientsNo. of events5-year PFSP
Estimate95% CI
All patients      
 p53 negative 20 10 55% 37–82  
 p53 positive 28 18 35% 21–59 0.33 
Hormone receptor negative      
 p53 negative 9 5 44% 21–92  
 p53 positive 21 14 33% 18–61  
Hormone receptor positive      
 p53 negative 10 5 60% 36–100  
 p53 positive 5 3 40% 14–100 0.61 
Nuclear grade 2      
 p53 negative 7 4 57% 30–100  
 p53 positive 4 1 75% 43–100  
Nuclear grade 3      
 p53 negative 11 5 55% 32–94  
 p53 positive 23 17 25% 12–52 0.33 
No pCR      
 p53 negative 16 10 44% 25–76  
 p53 positive 23 16 30% 16–56  
pCR      
 p53 negative 4 0    
 p53 positive 5 2 60% 29–100 0.38 
No. of patientsNo. of events5-year PFSP
Estimate95% CI
All patients      
 p53 negative 20 10 55% 37–82  
 p53 positive 28 18 35% 21–59 0.33 
Hormone receptor negative      
 p53 negative 9 5 44% 21–92  
 p53 positive 21 14 33% 18–61  
Hormone receptor positive      
 p53 negative 10 5 60% 36–100  
 p53 positive 5 3 40% 14–100 0.61 
Nuclear grade 2      
 p53 negative 7 4 57% 30–100  
 p53 positive 4 1 75% 43–100  
Nuclear grade 3      
 p53 negative 11 5 55% 32–94  
 p53 positive 23 17 25% 12–52 0.33 
No pCR      
 p53 negative 16 10 44% 25–76  
 p53 positive 23 16 30% 16–56  
pCR      
 p53 negative 4 0    
 p53 positive 5 2 60% 29–100 0.38 

Abbreviation: CI, confidence interval.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept